ID   EPHA7_HUMAN             Reviewed;         998 AA.
AC   Q15375; A0AUX7; B2R8W1; B7ZLJ9; B7ZLK0; Q59G40; Q5VTU0; Q8N368;
AC   Q9H124;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Ephrin type-A receptor 7;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 3;
DE            Short=EHK-3;
DE   AltName: Full=EPH-like kinase 11;
DE            Short=EK11;
DE            Short=hEK11;
DE   Flags: Precursor;
GN   Name=EPHA7; Synonyms=EHK3, HEK11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4), AND
RP   VARIANT VAL-138.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=9267020;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [8]
RP   FUNCTION IN MAP2K1; MAP2K2; MAPK1 AND MAPK3 PHOSPHORYLATION.
RX   PubMed=17726105; DOI=10.1073/pnas.0703211104;
RA   Nakanishi H., Nakamura T., Canaani E., Croce C.M.;
RT   "ALL1 fusion proteins induce deregulation of EphA7 and ERK
RT   phosphorylation in human acute leukemias.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14442-14447(2007).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 5).
RX   PubMed=20126984;
RA   Tsuboi M., Mori H., Bunai T., Kageyama S., Suzuki M., Okudela K.,
RA   Takamochi K., Ogawa H., Niwa H., Shinmura K., Sugimura H.;
RT   "Secreted form of EphA7 in lung cancer.";
RL   Int. J. Oncol. 36:635-640(2010).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 32-204.
RA   Walker J.R., Yermekbayeva L., Seitova A., Kania J., Bountra C.,
RA   Weigelt J., Arrowsmith C.H., Edwards A.M., Bochkarev A.,
RA   Dhe-Paganon S.;
RT   "Ephrin A7 ligand binding domain.";
RL   Submitted (JUN-2010) to the PDB data bank.
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-371.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-138; LYS-170; ARG-232; SER-278 AND
RP   SER-903.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling. Among GPI-anchored ephrin-A ligands, EFNA5 is a
CC       cognate/functional ligand for EPHA7 and their interaction
CC       regulates brain development modulating cell-cell adhesion and
CC       repulsion. Has a repellent activity on axons and is for instance
CC       involved in the guidance of corticothalamic axons and in the
CC       proper topographic mapping of retinal axons to the colliculus. May
CC       also regulate brain development through a caspase(CASP3)-dependent
CC       proapoptotic activity. Forward signaling may result in activation
CC       of components of the ERK signaling pathway including MAP2K1,
CC       MAP2K2, MAPK1 AND MAPK3 which are phosphorylated upon activation
CC       of EPHA7. {ECO:0000269|PubMed:17726105}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The
CC       heterotetramer is composed of an ephrin dimer and a receptor
CC       dimer. Oligomerization is probably required to induce biological
CC       responses (By similarity). Interacts (via PDZ-binding motif) with
CC       GRIP1 and PICK1 (via PDZ domain) (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P52793:Efna1 (xeno); NbExp=2; IntAct=EBI-1383428, EBI-5241529;
CC       P29317:EPHA2; NbExp=3; IntAct=EBI-1383428, EBI-702104;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=EPHA7-FL;
CC         IsoId=Q15375-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15375-2; Sequence=VSP_014382;
CC         Note=May be due to a competing donor splice site.;
CC       Name=3;
CC         IsoId=Q15375-3; Sequence=VSP_014380, VSP_014381;
CC         Note=No experimental confirmation available. Ref.6 (AAH27940)
CC         sequence is in conflict in position: 278:R->C. {ECO:0000305};
CC       Name=4;
CC         IsoId=Q15375-4; Sequence=VSP_041945;
CC         Note=No experimental confirmation available.;
CC       Name=5; Synonyms=EPHA7-S;
CC         IsoId=Q15375-5; Sequence=VSP_041943, VSP_041944;
CC         Note=Expressed in lung cancer cells, lacks the kinase domain and
CC         is most probably secreted.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92506.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA7ID40466ch6q16.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36642; AAA74243.1; -; mRNA.
DR   EMBL; AK313529; BAG36308.1; -; mRNA.
DR   EMBL; AB209269; BAD92506.1; ALT_INIT; mRNA.
DR   EMBL; AL121966; CAC19520.2; -; Genomic_DNA.
DR   EMBL; AL354857; CAH72780.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH73650.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL354857; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL121966; CAI19722.1; -; Genomic_DNA.
DR   EMBL; AL354857; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48518.1; -; Genomic_DNA.
DR   EMBL; BC027940; AAH27940.1; -; mRNA.
DR   EMBL; BC126125; AAI26126.1; -; mRNA.
DR   EMBL; BC126151; AAI26152.1; -; mRNA.
DR   EMBL; BC143857; AAI43858.1; -; mRNA.
DR   EMBL; BC143858; AAI43859.1; -; mRNA.
DR   CCDS; CCDS5031.1; -. [Q15375-1]
DR   CCDS; CCDS75494.1; -. [Q15375-3]
DR   PIR; I58351; I58351.
DR   RefSeq; NP_001275558.1; NM_001288629.1. [Q15375-2]
DR   RefSeq; NP_001275559.1; NM_001288630.1. [Q15375-3]
DR   RefSeq; NP_004431.1; NM_004440.3. [Q15375-1]
DR   RefSeq; XP_005248726.1; XM_005248669.2. [Q15375-4]
DR   UniGene; Hs.73962; -.
DR   PDB; 2REI; X-ray; 1.60 A; A=590-899.
DR   PDB; 3DKO; X-ray; 2.00 A; A=590-899.
DR   PDB; 3H8M; X-ray; 2.10 A; A/B=919-990.
DR   PDB; 3NRU; X-ray; 2.30 A; A/B/C/D/E/F/G/H/I/J/K/L=32-204.
DR   PDBsum; 2REI; -.
DR   PDBsum; 3DKO; -.
DR   PDBsum; 3H8M; -.
DR   PDBsum; 3NRU; -.
DR   ProteinModelPortal; Q15375; -.
DR   SMR; Q15375; -.
DR   BioGrid; 108359; 43.
DR   IntAct; Q15375; 10.
DR   MINT; MINT-1538326; -.
DR   STRING; 9606.ENSP00000358309; -.
DR   BindingDB; Q15375; -.
DR   ChEMBL; CHEMBL4602; -.
DR   DrugBank; DB07970; 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide.
DR   GuidetoPHARMACOLOGY; 1827; -.
DR   iPTMnet; Q15375; -.
DR   PhosphoSitePlus; Q15375; -.
DR   SwissPalm; Q15375; -.
DR   BioMuta; EPHA7; -.
DR   DMDM; 146345416; -.
DR   EPD; Q15375; -.
DR   MaxQB; Q15375; -.
DR   PaxDb; Q15375; -.
DR   PeptideAtlas; Q15375; -.
DR   PRIDE; Q15375; -.
DR   Ensembl; ENST00000369297; ENSP00000358303; ENSG00000135333. [Q15375-3]
DR   Ensembl; ENST00000369303; ENSP00000358309; ENSG00000135333. [Q15375-1]
DR   GeneID; 2045; -.
DR   KEGG; hsa:2045; -.
DR   UCSC; uc003poe.5; human. [Q15375-1]
DR   CTD; 2045; -.
DR   DisGeNET; 2045; -.
DR   GeneCards; EPHA7; -.
DR   HGNC; HGNC:3390; EPHA7.
DR   HPA; CAB010496; -.
DR   MIM; 602190; gene.
DR   neXtProt; NX_Q15375; -.
DR   OpenTargets; ENSG00000135333; -.
DR   PharmGKB; PA27822; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q15375; -.
DR   KO; K05108; -.
DR   OMA; TRHPSWI; -.
DR   OrthoDB; EOG091G00W0; -.
DR   PhylomeDB; Q15375; -.
DR   TreeFam; TF315608; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q15375; -.
DR   SIGNOR; Q15375; -.
DR   ChiTaRS; EPHA7; human.
DR   EvolutionaryTrace; Q15375; -.
DR   GeneWiki; EPHA7; -.
DR   GenomeRNAi; 2045; -.
DR   PRO; PR:Q15375; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000135333; -.
DR   CleanEx; HS_EPHA7; -.
DR   Genevisible; Q15375; HS.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB.
DR   GO; GO:0045499; F:chemorepellent activity; ISS:UniProtKB.
DR   GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0048755; P:branching morphogenesis of a nerve; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050919; P:negative chemotaxis; ISS:UniProtKB.
DR   GO; GO:0048671; P:negative regulation of collateral sprouting; IEA:Ensembl.
DR   GO; GO:0051964; P:negative regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0072178; P:nephric duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0016310; P:phosphorylation; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0022407; P:regulation of cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   CDD; cd10485; EphR_LBD_A7; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034283; EphA7_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell membrane; Complete proteome; Developmental protein; Glycoprotein;
KW   Kinase; Membrane; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    998       Ephrin type-A receptor 7.
FT                                /FTId=PRO_0000016818.
FT   TOPO_DOM     28    555       Extracellular. {ECO:0000255}.
FT   TRANSMEM    556    576       Helical. {ECO:0000255}.
FT   TOPO_DOM    577    998       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       32    210       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      331    441       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      442    537       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      633    894       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      923    987       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     639    647       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       996    998       PDZ-binding. {ECO:0000255}.
FT   COMPBIAS    192    328       Cys-rich.
FT   ACT_SITE    758    758       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     665    665       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     608    608       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     614    614       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     791    791       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     940    940       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    410    410       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     278    279       PC -> RK (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014380.
FT   VAR_SEQ     280    998       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014381.
FT   VAR_SEQ     442    450       APSQVSGVM -> GMFCVYLH (in isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_041943.
FT   VAR_SEQ     451    998       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_041944.
FT   VAR_SEQ     540    544       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_014382.
FT   VAR_SEQ     600    604       FKFPG -> C (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041945.
FT   VARIANT     138    138       I -> V (in dbSNP:rs2278107).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_022105.
FT   VARIANT     170    170       E -> K (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042150.
FT   VARIANT     232    232       G -> R (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042151.
FT   VARIANT     278    278       P -> S (in dbSNP:rs2278106).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_022106.
FT   VARIANT     371    371       R -> W (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs371089003).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036090.
FT   VARIANT     903    903       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042152.
FT   STRAND       33     37       {ECO:0000244|PDB:3NRU}.
FT   STRAND       48     51       {ECO:0000244|PDB:3NRU}.
FT   STRAND       54     61       {ECO:0000244|PDB:3NRU}.
FT   STRAND       67     74       {ECO:0000244|PDB:3NRU}.
FT   STRAND       78     80       {ECO:0000244|PDB:3NRU}.
FT   STRAND       83     86       {ECO:0000244|PDB:3NRU}.
FT   STRAND       96    106       {ECO:0000244|PDB:3NRU}.
FT   TURN        109    111       {ECO:0000244|PDB:3NRU}.
FT   STRAND      121    132       {ECO:0000244|PDB:3NRU}.
FT   HELIX       140    142       {ECO:0000244|PDB:3NRU}.
FT   STRAND      144    150       {ECO:0000244|PDB:3NRU}.
FT   STRAND      168    174       {ECO:0000244|PDB:3NRU}.
FT   STRAND      178    190       {ECO:0000244|PDB:3NRU}.
FT   STRAND      192    202       {ECO:0000244|PDB:3NRU}.
FT   HELIX       611    613       {ECO:0000244|PDB:2REI}.
FT   STRAND      614    616       {ECO:0000244|PDB:2REI}.
FT   HELIX       617    624       {ECO:0000244|PDB:2REI}.
FT   HELIX       630    632       {ECO:0000244|PDB:2REI}.
FT   STRAND      633    641       {ECO:0000244|PDB:2REI}.
FT   STRAND      643    652       {ECO:0000244|PDB:2REI}.
FT   STRAND      655    657       {ECO:0000244|PDB:3DKO}.
FT   STRAND      660    666       {ECO:0000244|PDB:2REI}.
FT   HELIX       673    686       {ECO:0000244|PDB:2REI}.
FT   STRAND      697    701       {ECO:0000244|PDB:2REI}.
FT   STRAND      703    705       {ECO:0000244|PDB:2REI}.
FT   STRAND      708    712       {ECO:0000244|PDB:2REI}.
FT   HELIX       719    725       {ECO:0000244|PDB:2REI}.
FT   TURN        726    728       {ECO:0000244|PDB:2REI}.
FT   HELIX       732    751       {ECO:0000244|PDB:2REI}.
FT   HELIX       761    763       {ECO:0000244|PDB:2REI}.
FT   STRAND      764    766       {ECO:0000244|PDB:2REI}.
FT   STRAND      772    774       {ECO:0000244|PDB:2REI}.
FT   HELIX       800    802       {ECO:0000244|PDB:2REI}.
FT   HELIX       805    810       {ECO:0000244|PDB:2REI}.
FT   HELIX       815    830       {ECO:0000244|PDB:2REI}.
FT   TURN        836    839       {ECO:0000244|PDB:2REI}.
FT   HELIX       842    850       {ECO:0000244|PDB:2REI}.
FT   HELIX       863    872       {ECO:0000244|PDB:2REI}.
FT   HELIX       877    879       {ECO:0000244|PDB:2REI}.
FT   HELIX       883    895       {ECO:0000244|PDB:2REI}.
FT   HELIX       897    899       {ECO:0000244|PDB:2REI}.
FT   HELIX       928    934       {ECO:0000244|PDB:3H8M}.
FT   HELIX       938    940       {ECO:0000244|PDB:3H8M}.
FT   HELIX       941    946       {ECO:0000244|PDB:3H8M}.
FT   HELIX       952    956       {ECO:0000244|PDB:3H8M}.
FT   HELIX       960    965       {ECO:0000244|PDB:3H8M}.
FT   HELIX       971    988       {ECO:0000244|PDB:3H8M}.
SQ   SEQUENCE   998 AA;  112097 MW;  479B9CA0D2BB06EB CRC64;
     MVFQTRYPSW IILCYIWLLR FAHTGEAQAA KEVLLLDSKA QQTELEWISS PPNGWEEISG
     LDENYTPIRT YQVCQVMEPN QNNWLRTNWI SKGNAQRIFV ELKFTLRDCN SLPGVLGTCK
     ETFNLYYYET DYDTGRNIRE NLYVKIDTIA ADESFTQGDL GERKMKLNTE VREIGPLSKK
     GFYLAFQDVG ACIALVSVKV YYKKCWSIIE NLAIFPDTVT GSEFSSLVEV RGTCVSSAEE
     EAENAPRMHC SAEGEWLVPI GKCICKAGYQ QKGDTCEPCG RGFYKSSSQD LQCSRCPTHS
     FSDKEGSSRC ECEDGYYRAP SDPPYVACTR PPSAPQNLIF NINQTTVSLE WSPPADNGGR
     NDVTYRILCK RCSWEQGECV PCGSNIGYMP QQTGLEDNYV TVMDLLAHAN YTFEVEAVNG
     VSDLSRSQRL FAAVSITTGQ AAPSQVSGVM KERVLQRSVE LSWQEPEHPN GVITEYEIKY
     YEKDQRERTY STVKTKSTSA SINNLKPGTV YVFQIRAFTA AGYGNYSPRL DVATLEEATG
     KMFEATAVSS EQNPVIIIAV VAVAGTIILV FMVFGFIIGR RHCGYSKADQ EGDEELYFHF
     KFPGTKTYID PETYEDPNRA VHQFAKELDA SCIKIERVIG AGEFGEVCSG RLKLPGKRDV
     AVAIKTLKVG YTEKQRRDFL CEASIMGQFD HPNVVHLEGV VTRGKPVMIV IEFMENGALD
     AFLRKHDGQF TVIQLVGMLR GIAAGMRYLA DMGYVHRDLA ARNILVNSNL VCKVSDFGLS
     RVIEDDPEAV YTTTGGKIPV RWTAPEAIQY RKFTSASDVW SYGIVMWEVM SYGERPYWDM
     SNQDVIKAIE EGYRLPAPMD CPAGLHQLML DCWQKERAER PKFEQIVGIL DKMIRNPNSL
     KTPLGTCSRP ISPLLDQNTP DFTTFCSVGE WLQAIKMERY KDNFTAAGYN SLESVARMTI
     EDVMSLGITL VGHQKKIMSS IQTMRAQMLH LHGTGIQV
//
